Endovascular therapy or conventional vascular surgery? A complex choice
Roy K. Greenberg, MD
Director, Endovascular Research, Department of Vascular Surgery, The Cleveland Clinic
Address: Roy K. Greenberg, MD, Director, Endovascular Research, Department of Vascular Surgery, S40, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: firstname.lastname@example.org
The author has indicated that he has received grant or research support from the Boston Scientific, Cook, Cordis Endovascular, Jomed, and Vascutek corporations and serves as a consultant for the Boston Scientific and Cook corporations.
This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTEndovascular therapy and open vascular surgery have advantages and disadvantages. A single therapeutic option is rarely ideal for all patients. Rather, the two options are tools that are best used selectively; their availability allows for therapy to be tailored to optimize patient care.